SINGAPORE, July 16, 2013 /PRNewswire/ - Zecotek Photonics Inc. (TSX-V: ZMS; OTCPK: ZMSPF; Frankfurt: W1I), a developer of leading-edge photonics technologies for medical,
industrial and scientific markets, today announced that its wholly
owned subsidiary Zecotek Imaging Systems Pte. Ltd. has signed a joint
collaboration partnership agreement with Hamamatsu Photonics (Tokyo:
6965) of Japan to commercialize existing imaging technologies and to
collaborate on the upgrade and manufacture of photo detectors,
integrated detector modules (IDM) and associated electronics and data
acquisition modules for the imaging markets at large. With
approximately US$1 billion of annual sales Hamamatsu is the world's
leading supplier of optoelectronics components including photo
multiplier tubes and photo-diodes used in positron emission tomography
(PET) medical scanners, the European Organization for Nuclear Research
(CERN) projects and other industrial and scientific applications.
"This agreement represents a pivotal and historic event for Zecotek.
With Hamamatsu's strong technological, manufacturing and commercial
expertise, our two companies will have the capacity to provide
substantial value to the medical imaging and high energy physics
industries," said Dr. A.F. Zerrouk, Chairman, President, and CEO of
Zecotek Photonics Inc. "Hamamatsu is the world leading developer and
supplier of optoelectronics components to PET (Positron Emission
Tomography) medical scanner OEM's and manufacturers, to the bio-medical
industries, as well as to CERN with whom they have a very close and
long term relationship. By combining our efforts, we can accelerate
the commercialization of Zecotek's imaging technologies for the
medical, industrial and research applications. I have full confidence
in the ability of Hamamatsu's management and technical team to create
key value in this very welcomed relationship."
"We are very pleased to join forces and provide added value to Zecotek's
imaging technologies," said Mr. Koei Yamamoto General Managing
Director, Hamamatsu Photonics. "We will use our well established R&D,
technological and manufacturing expertise to strengthen Zecotek's
existing technological results and products. We believe this to be a
powerful and symbiotic relationship."
The agreement combines the strengths of both organizations into a
collaborative program, whereby Zecotek's patented and patent pending
imaging technologies can benefit from the technological expertise and
marketing capabilities of Hamamatsu. Hamamatsu will take over the
manufacturing and marketing of most of Zecotek's proprietary imaging
technologies, including the commercialization of LFS crystals,
solid-state MAPD photo detectors and any other photo-detector variants
innovated by Zecotek. Hamamatsu becomes the exclusive sales channel
for Zecotek' patented protected LFS scintillation crystal and future
generations of the scintillation material. Hamamatsu will take the lead
on the technological enhancement, large-scale manufacturing and
marketing of all Zecotek's imaging technologies.
Zecotek and Hamamatsu will establish a joint program to improve existing
versions of photo-detectors and imaging modules, for immediate
commercialization and develop new innovative ones for future markets.
Both parties will retain full ownership to all their respective patents
and intellectual property brought into the collaboration. The
manufacturing and commercialization of existing and new technologies
will be performed by Hamamatsu.
Zecotek Imaging Systems has research laboratory facilities in Singapore
and Russia. The market adoption of its imaging technologies is
advancing and the Zecotek wholly owned subsidiary has established close
working partnerships with the European Organization for Nuclear
Research (CERN) in Switzerland, NuCare Medical Systems in South Korea
and University of Washington in Seattle.
Hamamatsu Photonics is a world-leading developer and manufacturer of
opto-electronic components and systems and employs over 4000 staff
worldwide. For more than 50 years it has been bringing innovative,
state-of-the art optoelectronic components and systems to the global
market. With production facilities, business locations and associated
companies throughout Asia, Europe and North America, it is a
world-leading manufacturer of products that are designed to cover the
entire optical spectrum and are the optimum solution for a wide variety
of applications such as analytical instruments, medical diagnostics,
biotechnology, consumer electronics and industrial control.
About Hamamatsu Photonics K.K.
Hamamatsu Photonics K.K. (Japan) is a leading manufacturer of devices
for the generation and measurement of infrared, visible, and
ultraviolet light. These devices include photomultiplier tubes,
scientific light sources, opto-semiconductors, cameras, and specialized
imaging systems. Hamamatsu Photonics is dedicated to the advancement of
photonics through extensive research. This corporate philosophy results
in state-of-the-art products which are used throughout the world in
scientific, industrial, and commercial applications.
Zecotek Photonics Inc (TSX-V: ZMS; Frankfurt: W1I) is a photonics
technology company developing high-performance scintillation crystals,
photo detectors, positron emission tomography scanning technologies, 3D
auto-stereoscopic displays, and lasers for applications in medical,
high-tech and industrial sectors. Founded in 2004, Zecotek
operates three divisions: Imaging Systems, Laser Systems and 3D Display
Systems with labs located in Canada, Korea, Russia, Singapore and
U.S.A. The management team is focused on building shareholder value by
commercializing over 50 patented and patent pending novel photonic
technologies directly and through strategic alliances and joint
ventures with leading industry partners such as Hamamatsu Photonics
(Japan), the European Organization for Nuclear Research (Switzerland),
Beijing Opto-Electronics Technology Co. Ltd. (China), NuCare Medical
Systems (South Korea), and National NanoFab Center (South Korea). For
more information visit www.zecotek.com, follow @zecotek on Twitter and "like" us in Facebook at www.facebook.com/zecotek.
This press release may contain forward-looking statements that are based
on management's expectations, estimates, projections and assumptions.
These statements are not guarantees of future performance and involve
certain risks and uncertainties, which are difficult to predict.
Therefore, actual future results and trends may differ materially from
what may have been stated.
Neither the TSX Venture Exchange nor its Regulation Service Provider (as
that term is defined in the policies of the TSX Venture Exchange)
accepts responsibility for the adequacy or accuracy of the content of
this news release. If you would like to receive news from Zecotek in
the future please visit the corporate website at www.zecotek.com.
SOURCE Zecotek Photonics Inc.